Zacks Investment Research
29 Oct 2025, 14:36 UTC · 47w ago
Verdict
Headline takes no side. We score MBOT +0.60 across four claims — strongly bullish.
+0.60strongly bullish
More positive than 75% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
The consensus EPS estimate for Microbot Medical Inc. (MBOT) has increased by 20% over the last 30 days.
More positive than 78% of claims this week
Microbot Medical Inc. (MBOT) currently holds a Zacks Rank #2 (Buy), placing it in the top 20% of ranked stocks.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 65% of claims this week
MBOT's Relative Strength Index (RSI) is 26.65, indicating the stock is in oversold territory.
More positive than 53% of claims this week
MBOT stock has decreased by 28.2% over the past four weeks.
More negative than 64% of claims this week
Which stocks this story touches
More positive than 75% of ticker scores this week
The company has a Zacks Rank #2 (Buy), positive earnings estimate revisions, and is considered oversold with potential for a rebound.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−41.8%
Price is moving against the score
$1.27 vs $2.19 close before publication (Oct 28) · not market-adjusted
MBOT chart →
